companydata.dkNBCD A/S: Financial statements 2013
CVR: 30582462
NBCD A/S (CVR 30582462) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -3,384,452 and a net result of DKK -11,792,867. Equity amounted to DKK -22,863,732.
- Gross Profit
- -3,384,452 kr.
- Profit/Loss
- -11,792,867 kr.
- Equity
- -22,863,732 kr.
- Total Assets
- 35,999,769 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -3.4 mio. | -11.8 mio. | -22.9 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Find more companies like NBCD A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of October 1, 2013, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of NBCD A/S.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of NBCD A/S.
NBCD A/S has published its annual report for 2012.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.